About the Company
kalvista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $KALV News
KalVista Pharmaceuticals, Inc. (KALV)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
KalVista Pharmaceuticals Presents Real-World Data on Burden of Treatment and HAE Attack Journey at the 2024 HAEi Regional Conference Americas
SALISBURY, England, March 18, 2024--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage ...
KalVista Pharmaceuticals (KALV) Price Target Increased by 51.92% to 32.23
KalVista Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need.
KalVista Pharmaceuticals (NASDAQ: KALV)
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors. Its product ...
Buy Rating on KalVista Pharmaceuticals Backed by Sebetralstat’s Breakthrough in HAE Treatment
Analyst Andrew Fein of H.C. Wainwright reiterated a Buy rating on KalVista Pharmaceuticals (KALV – Research Report), with a price target ...
KalVista Pharmaceuticals to Participate in the Leerink Partners 2024 Global Biopharma Conference
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)-- KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the ...
KalVista Pharmaceuticals Inc KALV
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
KalVista Pharmaceuticals Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Kalvista Pharmaceuticals Inc (KALV)
CAMBRIDGE, Mass. & SALISBURY, England - KalVista Pharmaceuticals, Inc. (NASDAQ: NASDAQ:KALV) has received the Promising Innovative Medicine (PIM) designation for sebetralstat from ...
Loading the latest forecasts...